Zobrazeno 1 - 10
of 118
pro vyhledávání: '"SNIJDER, R.J."'
Publikováno v:
In IJC Heart & Vasculature August 2020 29
Publikováno v:
In Respiratory Medicine June 2020 167
Publikováno v:
In IJC Heart & Vasculature March 2019 22:163-168
Autor:
Vorselaars, V.M.M., Diederik, A., Prabhudesai, V., Velthuis, S., Vos, J.-A., Snijder, R.J., Westermann, C.J.J., Mulder, B.J., Ploos van Amstel, J.K., Mager, J.J., Faughnan, M.E., Post, M.C.
Publikováno v:
In International Journal of Cardiology 15 October 2017 245:114-118
Autor:
Willemink, M.J., van Es, H.W., Koobs, L., Morshuis, W.J., Snijder, R.J., van Heesewijk, J.P.M.
Publikováno v:
In Clinical Radiology March 2012 67(3):277-285
Autor:
Mathijssen, H., Huitema, M.P., Bakker, A.L.M., Mager, J.J., Snijder, R.J., Grutters, J.C., Post, M.C.
Publikováno v:
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases
Background: Pulmonary hypertension (PH) is a known complication of pulmonary sarcoidosis and is associated with higher morbidity and mortality. Currently, there are no approved PH-targeted therapies for sarcoidosis-associated pulmonary hypertension (
Autor:
AGTEROF, M.J. *, SCHUTGENS, R.E.G., SNIJDER, R.J., EPPING, G., PELTENBURG, H.G., POSTHUMA, E.F.M., HARDEMAN, J.A., VAN DER GRIEND, R., KOSTER, T., PRINS, M.H., BIESMA, D.H.
Publikováno v:
In Journal of Thrombosis and Haemostasis June 2010 8(6):1235-1241
Autor:
Orlova, V.V., Nahon, D.M., Cochrane, A., Cao, X., Freund, C., Hil, F. van den, Westermann, C.J.J., Snijder, R.J., Amstel, J.K.P. van, Dijke, P. ten, Lebrin, F., Mager, H.J., Mummery, C.L.
Publikováno v:
Stem Cell Reports, 17(7), 1536-1545. CELL PRESS
Hereditary hemorrhagic telangiectasia (HHT) is a genetic disease characterized by weak blood vessels. HHT1 is caused by mutations in the ENDOGLIN (ENG) gene. Here, we generated induced pluripotent stem cells (hiPSCs) from a patient with rare mosaic H
Objective: The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension following Ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::b44c24c84a6c6f163e21813473fd06ed
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102848
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102848
Objective: The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) foll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::1d3c4b89eb314ff93cb63176bc25cae3
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102729
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102729